Pages that link to "Q28823540"
Jump to navigation
Jump to search
The following pages link to Sonia Anand (Q28823540):
Displaying 36 items.
- Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals (Q27003308) (← links)
- Oral anticoagulant and antiplatelet therapy and peripheral arterial disease (Q28218519) (← links)
- A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease (Q28267020) (← links)
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease (Q29417023) (← links)
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study (Q29615729) (← links)
- Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci (Q30419436) (← links)
- Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies (Q30499949) (← links)
- Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies (Q33381588) (← links)
- Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height (Q34458862) (← links)
- Association of cyclooxygenase-2 genetic variant with cardiovascular disease (Q35608507) (← links)
- Effect of referral strategies on access to cardiac rehabilitation among women (Q35908784) (← links)
- The Canadian Healthy Infant Longitudinal Development (CHILD) birth cohort study: assessment of environmental exposures (Q36178431) (← links)
- Genetically determined height and coronary artery disease (Q36288162) (← links)
- Effectiveness of inpatient and outpatient strategies in increasing referral and utilization of cardiac rehabilitation: a prospective, multi-site study (Q36521300) (← links)
- No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis (Q37330353) (← links)
- Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design? (Q37377502) (← links)
- Gene-centric meta-analyses for central adiposity traits in up to 57 412 individuals of European descent confirm known loci and reveal several novel associations (Q37705562) (← links)
- Effect of cardiac rehabilitation referral strategies on utilization rates: a prospective, controlled study (Q37843053) (← links)
- A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score (Q40511223) (← links)
- The Canadian Healthy Infant Longitudinal Development (CHILD) Study: examining developmental origins of allergy and asthma (Q40841353) (← links)
- Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study (Q42781469) (← links)
- Effects of CYP2C19 genotype on outcomes of clopidogrel treatment (Q42846150) (← links)
- Fine mapping of the insulin-induced gene 2 identifies a variant associated with LDL cholesterol and total apolipoprotein B levels (Q42880563) (← links)
- Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. (Q45173221) (← links)
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial (Q46938524) (← links)
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial (Q47408050) (← links)
- External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry (Q47676989) (← links)
- Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial (Q47683660) (← links)
- Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease (Q51305542) (← links)
- Major Adverse Limb Events in Lower Extremity Peripheral Artery Disease: COMPASS Trial. (Q52655570) (← links)
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. (Q53098804) (← links)
- ERRATUM: Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height (Q56457854) (← links)
- Effect of PON1 Q192R Genetic Polymorphism on Clopidogrel Efficacy and Cardiovascular Events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events Trial and the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Va (Q58375650) (← links)
- Anita Anand (Q67442310) (← links)
- (Q91870471) (redirect page) (← links)
- Antithrombotics in stable peripheral artery disease (Q91870476) (← links)